1. Academic Validation
  2. Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023

Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023

  • Eur J Med Chem. 2023 Oct 5:258:115586. doi: 10.1016/j.ejmech.2023.115586.
Sheng Han 1 Yiming Lu 2
Affiliations

Affiliations

  • 1 School of Medicine, Shanghai University, Shanghai, China. Electronic address: hansheng@shu.edu.cn.
  • 2 School of Medicine, Shanghai University, Shanghai, China; Department of Critical Care Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: bluesluyi@sina.com.
Abstract

Human immunodeficiency virus (HIV) is the etiological agent of acquired immunodeficiency syndrome (AIDS). Nowadays, FDA has approved over thirty antiretroviral drugs grouped in six categories. Interestingly, one-third of these drugs contain different number of fluorine atoms. The introduction of fluorine to obtain drug-like compounds is a well-accepted strategy in medicinal chemistry. In this review, we summarized 11 fluorine-containing anti-HIV drugs, focusing on their efficacy, resistance, safety, and specific roles of fluorine in the development of each drug. These examples may be of help for the discovery of new drug candidates bearing fluorine in their structures.

Keywords

AIDS; FDA-Approved drugs; Fluorine; HIV.

Figures